厄洛替尼与标准一线化疗作为新辅助治疗ⅢA-N2期EGFR突变阳性非小细胞肺癌患者的疗效比较被引量：6

Erlotinib Versus Standard First-Line Chemotherapy as Neoadjuvant Treatment for Stage Ⅲ A-N2 EGFR-Mutation Positive Non-Small Cell Lung Cancer

下载PDF

导出

摘要 1文献来源Zhong WZ,Wu YL,Chen KN,et al.CTONG1103:Erlotinib versus Gemcitabine plus Cisplatin as neoadjuvant treatment for stage Ⅲ A-N2 EGFR-mutation positive non-small-cell lung cancer(EMERGING):A randomised study[J].Ann Oncol,2018,29(8S):LBA48_PR.2证据水平1b。3背景Ⅲ A-N2期非小细胞肺癌(non-small-cell lung cancer,NSCLC)具有相当大的异质性,根据同侧纵隔淋巴结受累程度不同分为Ⅲ A1~Ⅲ A4(Robinson分类),而目前治疗方案各异,包括放化疗、手术切除后化疗、新辅助治疗后手术切除。

作者康晓征闫万璞陈克能唐文芳 KANG Xiao-zheng;YAN Wan-pu;CHEN Ke-neng;TANG Wen-fang(Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education),Department of Thoracic Surgery,Peking University Cancer Hospital and Institute,Beijing 100142,China)

机构地区北京大学肿瘤医院胸外科恶性肿瘤发病机制及转化研究教育部重点实验室广东省人民医院肿瘤中心广东省医学科学院广东省肺癌研究所

出处《循证医学》 2019年第1期30-33,共4页 The Journal of Evidence-Based Medicine

关键词非小细胞肺癌局部晚期 EGFR突变阳性厄洛替尼新辅助治疗 non-small cell lung cancer local advanced EGFR-mutation positive Erlotinib neoadjuvant treatment

分类号 R734.2 [医药卫生—肿瘤]

引文网络
相关文献

参考文献1

1戴亮,康晓征,陈克能.通过第8版肺癌N分期修订建议看纵隔镜在肺癌诊疗中的重要性[J].临床外科杂志,2016,24(7):500-502. 被引量：2

二级参考文献21

1Harken DE, Black H, Clauss R, et al. A simple cervicomediastinal ex- ploration for tissue diagnosis of intrathoracic disease ; with comments on the recognition of inoperable carcinoma of the lung [ J 1- N Engl J Med,1954,251 (26) :1041-1044.
2Carlens E. Mediastinoseopy:a method for inspection and tissue biopsy in the superior mediastinum[J].Dis Chest, 1959,36 : 343-352.
3Pearson FG. An evaluation of mediastinoscopy in the management of presumably operable bronchial carcinoma[J].J Thorac Cardiovase Surg, 1968,55 ( 5 ) :617-625.
4Lerut T, De Leyn P, Coosemans W, et al. Cervical videomediastinoseo- py [ J ]. Thorac Surg Clin, 2010,20 ( 2 ) : 195-206.
5Leschber G, Holinka G, Linder A. Video-assisted mediastinoscopic lymphadenectomy (VAMLA)-a method for systematic mediastinal lymphnode dissection [ J 1. Eur J Cardiothorae Surg, 2003,24 ( 2 ) : 192-195.
6Ramnath N, Dilling TJ, Harris LJ, et al. Treatment of stage III non- small cell lung cancer:Diagnosis and management of lung cancer,3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines [ J ]. Chest,2013,143 ( 5 Suppl) : e314S-340S.
7Silvestri GA, Gonzalez AV, Jantz MA, et al. Methods for staging non- small cell lung cancer:Diagnosis and management of lung cancer,3rd ed: American College of Chest Physicians evidence-based clinicalpractice guidelines[ J]. Chest,2013,143 (5 Suppl) :e211 S-250S.
8Micames CG, McCrory DC, Pavey DA, et al. Endoscopic ultrasound- guided fine-needle aspiration for non-small cell lung cancer staging:A systematic review and metaanalysis [ J ]. Chest, 2007,131 ( 2 ) : 539- 548.
9Ginsberg R J, Rice TW, Goldberg M, et al. Extended cervical mediasti- noscopy. A single staging procedure for bronehogenie carcinoma of the left upper lobe [ J ]. J Yhorae Cardiovasc Surg, 1987,94 (5) :673<i78.
10McNeill TM, Chamberlain JM. Diagnostic anterior mediastinotomy. Ann Thorae Surg,1966,2(4) :532-539.